Report Code : CVMI1604202501 | Published Date : April 16, 2025
Market Overview
The global animal stem cell therapy industry was valued at USD 320 million in 2023 and is projected to grow at a CAGR of 18.2% through 2031, reaching USD 1.2 billion. This growth is driven by:
- Growing demand for regenerative medicine (60% of orthopedic cases now consider stem cell options)
- Increasing prevalence of chronic conditions: 1 in 5 dogs develops osteoarthritis.
- Advancements in cellular technology (3D bioprinting of cartilage scaffolds)
Key Applications:
- Orthopedics (55% market share) – Conditions like arthritis and tendon or ligament injuries
- Dermatology (XX%) – Chronic wounds, burns
- Oncology (XX%) – Immunotherapy applications
- Other (XX%) – Neurological, renal diseases
Therapy Types:
- Autologous (70%) – Patient’s own cells
- Allogeneic (30%) – Off-the-shelf products
Growth Drivers
1. Osteoarthritis Epidemic
- 50% of dogs over 8 years show radiographic signs
- VetStem’s adipose-derived therapy reduces pain in 85% of cases
2. Sports & Working Animals
- Equine tendon repair success rates can reach up to 75%.
- Military and police K9 programs adopt preventive therapies.
3. Regulatory Approvals
- FDA’s 2023 VSTA pathway accelerates approvals
- EU’s ATMP classification clarifies requirements
4. Pet Humanization Trend
- 70% of owners choose biologics over NSAIDs when affordable
- Insurance coverage expanding (Trupanion covers 50% of costs)
Regional Analysis
Region |
Market Share |
Key Development |
North America |
45% |
80% of veterinary schools offer training |
Europe |
XX% |
Strong research in allogeneic products |
Asia-Pacific |
XX% |
China’s USD 200M regenerative medicine initiative |
Latin America |
XX% |
Brazil leads in equine applications |
Case Study:
- UC Davis’ Feline CKD Trial showed 40% renal function improvement with MSC therapy
Competitive Landscape
Top 5 Players:
- VetStem (40% share) – Patented adipose technology
- MediVet Biologics (XX%) – Point-of-care systems
- Ardent Animal Health (XX%) – Allogeneic cartilage regeneration
- CellX (XX%) – 3D bioprinted implants
- Regeneus (XX%) – Canine osteoarthritis off-the-shelf product
Recent Developments:
- Zoetis’ $ 250 million acquisition of a stem cell startup
- First approval of CRISPR-edited MSCs for feline diabetes
Reasons To Buy

Scope

- VetStem
- MediVet Biologics
- Ardent Animal Health
- CellX
- Regeneus
Animal Stem Cell Therapy Industry Report
- 1. Animal Stem Cell Therapy Industry Research Report
- 1.1 Study Objectives
- 1.2 Animal Stem Cell Therapy Industry - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2. Animal Stem Cell Therapy Industry Research Report - Preface
- 2.1 Animal Stem Cell Therapy Industry Research Report – Detailed Scope and Definitions
- 2.1.1 Key Applications:
- 2.1.2 Therapy Types:
- 2.1.3 By Region
3. Animal Stem Cell Therapy Industry Dynamics - 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – Key Applications:, Therapy Types:, By Country
- 3.3. Opportunities – Key Applications:, Therapy Types:, By Country
- 3.4. Trends – Key Applications:, Therapy Types:, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Animal Stem Cell Therapy Industry Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 4. Animal Stem Cell Therapy Industry Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
- 5. Animal Stem Cell Therapy Industry, Key Applications:, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 5.2 Dermatology
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 5.3 Oncology
- 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 5.4 Other
- 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 6.2 Allogeneic
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
5.1 Orthopedics
-
6.1 Autologous
- 7. Animal Stem Cell Therapy Industry Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
7.1 North America
- 8. North America Animal Stem Cell Therapy Industry Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 8.1.1 Orthopedics
- 8.1.2 Dermatology
- 8.1.3 Oncology
- 8.1.4 Other
- 8.2.1 Autologous
- 8.2.2 Allogeneic
- 8.3.1 United States
- 8.3.2 Canada
- 8.4 North America Animal Stem Cell Therapy Industry – Opportunity Analysis Index, Key Applications:, Therapy Types:, and Country, 2024 - 2031
- 8.5 Regional Trends Analysis 8.6 North America Animal Stem Cell Therapy Industry Research Report - Company Profiles
- 8.6.1 Company 1 (United States)
- 8.6.2 Company 2 (Canada)
- 8.6.3 Company 3 (Canada)
- 9.1.1 Orthopedics
- 9.1.2 Dermatology
- 9.1.3 Oncology
- 9.1.4 Other
- 9.2.1 Autologous
- 9.2.2 Allogeneic
- 9.3.1 Germany
- 9.3.2 United Kingdom
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Russia
- 9.4 Europe Animal Stem Cell Therapy Industry – Opportunity Analysis Index, Key Applications:, Therapy Types:, and Country, 2024 - 2031
- 9.5 Regional Trends Analysis 9.6 Europe Animal Stem Cell Therapy Industry Research Report - Company Profiles
- 9.6.1 Company 1 (Germany)
- 9.6.2 Company 2 (United Kingdom)
- 9.6.3 Company 3 (United Kingdom)
- 10.1.1 Orthopedics
- 10.1.2 Dermatology
- 10.1.3 Oncology
- 10.1.4 Other
- 10.2.1 Autologous
- 10.2.2 Allogeneic
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Australia & New Zealand
- 10.3.6 ASEAN
- 10.4 Asia-Pacific Animal Stem Cell Therapy Industry – Opportunity Analysis Index, Key Applications:, Therapy Types:, and Country, 2024 - 2031
- 10.5 Regional Trends Analysis 10.6 Asia-Pacific Animal Stem Cell Therapy Industry Research Report - Company Profiles
- 10.6.1 Company 1 (China)
- 10.6.2 Company 2 (Japan)
- 10.6.3 Company 3 (Japan)
- 11.1.1 Orthopedics
- 11.1.2 Dermatology
- 11.1.3 Oncology
- 11.1.4 Other
- 11.2.1 Autologous
- 11.2.2 Allogeneic
- 11.3.1 Brazil
- 11.3.2 Mexico
- 11.3.3 Argentina
- 11.3.4 Peru
- 11.3.5 Colombia
- 11.3.6 Rest of Latin America
- 11.4 Latin America Animal Stem Cell Therapy Industry – Opportunity Analysis Index, Key Applications:, Therapy Types:, and Country, 2024 - 2031
- 11.5 Regional Trends Analysis 11.6 Latin America Animal Stem Cell Therapy Industry Research Report - Company Profiles
- 11.6.1 Company 1 (Brazil)
- 11.6.2 Company 2 (Mexico)
- 11.6.3 Company 3 (Mexico)
- 12.1.1 Orthopedics
- 12.1.2 Dermatology
- 12.1.3 Oncology
- 12.1.4 Other
- 12.2.1 Autologous
- 12.2.2 Allogeneic
- 12.3.1 Saudi Arabia
- 12.3.2 UAE
- 12.3.3 South Africa
- 12.3.4 Egypt
- 12.3.5 Israel
- 12.3.6 Rest of Middle East and Africa
- 12.4 Middle East and Africa Animal Stem Cell Therapy Industry – Opportunity Analysis Index, Key Applications:, Therapy Types:, and Country, 2024 - 2031
- 12.5 Regional Trends Analysis 12.6 Middle East and Africa Animal Stem Cell Therapy Industry Research Report - Company Profiles
- 12.6.1 Company 1 (Saudi Arabia)
- 12.6.2 Company 2 (UAE)
- 12.6.3 Company 3 (UAE)
- 13.1 Strategic Dashboard of Top Market Players 13.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
- 13.2.1 VetStem Biopharma
- 13.2.2 Medrego
- 13.2.3 Ardent Animal Health
- 13.2.4 Animal Cell Therapies
- 13.2.5 Cell Therapy Sciences
- 13.2.6 ReGeniVET
- 13.2.7 Stem Cell Safari
- 13.2.8 Vetbiologics
- 13.2.9 Vetherapy
- 13.2.10 Companion Regenerative Therapies
- 13.2.11 Animal Biosciences
- 13.2.12 Pluristem Therapeutics
- 13.2.13 Boehringer Ingelheim
- 13.2.14 Zoetis
- 13.2.15 Smith+Nephew.
-
8.1 Key Applications: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
-
9.1 Key Applications: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
-
10.1 Key Applications: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
-
11.1 Key Applications: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
-
12.1 Key Applications: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 14. Data Collection Method and Research Approach
- 15. Principal Presumptions and Acronyms